Mortality Reduction After Oral Azithromycin Contingency: Mortality Study (MORDORIIMortY5)
Sponsor: Bill and Melinda Gates Foundation
This PHASE4 trial investigates Childhood Mortality and is currently completed. Bill and Melinda Gates Foundation leads this study, which shows 14 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE4
-
Sep 2022 — Dec 2022 [monthly]
Completed PHASE4
▶ Show 9 earlier versions
-
Sep 2021 — Sep 2022 [monthly]
Completed PHASE4
-
Apr 2021 — Sep 2021 [monthly]
Completed PHASE4
-
Jan 2021 — Apr 2021 [monthly]
Completed PHASE4
-
Oct 2020 — Jan 2021 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Jul 2020 — Oct 2020 [monthly]
Recruiting PHASE4
-
Jun 2019 — Jul 2020 [monthly]
Recruiting PHASE4
-
Jan 2019 — Jun 2019 [monthly]
Recruiting PHASE4
-
Jun 2018 — Jan 2019 [monthly]
Recruiting PHASE4
-
Dec 2017 — Jun 2018 [monthly]
Recruiting PHASE4
First recorded
Oct 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bill and Melinda Gates Foundation
- The Carter Center
- University of California, San Francisco
For direct contact, visit the study record on ClinicalTrials.gov .